Investing in youth brain capital is not just a moral imperative. It is an economic necessity. The post America Is Losing One of Its Most Precious Assets: Our Brain Power appeared first on MedCity News.

Takeda Pharmaceutical has secured an option on an Alzheimer’s disease immunotherapy from AC Immune that is on track to report its first Phase 2 data later this quarter. Exercising the option would make Takeda responsible for Phase 3 testing of the therapy, putting AC Immune in line for up to $2.1 billion in milestone payments. The post Takeda Commits...

The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today! The post Healthcare Investment Trends Take Center Stage at MedCity INVEST appeared first on MedCity News.

Eli Lilly-partnered Lycia Therapeutics will use its Series C financing to continue developing its internal pipeline of protein-degrading drugs. The startup is working to reach the clinic with drugs for autoimmune and inflammatory disorders. The post Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases...

According to new statistics from the Association of American Medical Colleges, for the second year in a row, students graduating from U.S. medical schools were less likely to apply this year for residency positions in states with abortion bans and other significant abortion restrictions. The post Medical Residents Are Increasingly Avoiding States With...

Hospitals are seeking to offset their expenses any way they can, and some are taking a “two-sided green” approach — meaning pursuing renewable energy initiatives that will save money in the long run. These hospitals are on track to save millions, and some already have. The post ‘Two-Sided Green’: How 4 Health Systems Are Saving Money With Renewable...